Wound Management Technologies divests e-health business to focus on wound care
This article was originally published in Clinica
Executive Summary
Wound Management Technologies (WMT) has sold off the Secure eHealth subsidiary it acquired two years ago in order to focus on its lead wound care product, CellerateRx. The two unnamed buyers had helped finance WMT's January 2010 acquisition of Secure eHealth, which specialises in developing software that provides community-based healthcare networks with secure access to electronic information.